BridgeMD
New treatment option for Breastfeeding, Exclusive
Official title MBSR and NLP, Postpartum Breastfeeding and Depression
ClinicalTrials.gov ID: NCT06628986
What this study is testing
- What it's testing
- The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 35, women only. Healthy volunteers may be eligible.
You may be able to join if
- 19-35 years old
- caesarean section
- primiparous
- breastfeeding women
You likely can't join if
- women who refused to participate in the research.
The study team makes the final eligibility decision.
Where it's taking place
- Sanliurfa, Eyalet/Yerleşke, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sanliurfa, Eyalet/Yerleşke, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.